Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;9(6):921-927.
doi: 10.21037/qims.2019.05.13.

Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography

Affiliations

Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography

Hassan M Ghoz et al. Quant Imaging Med Surg. 2019 Jun.

Abstract

Background: Magnetic resonance elastography (MRE) is a non-invasive test used to assess liver stiffness and fibrosis in chronic liver disease, which includes systemic iron overload. However, iron deposition by itself is associated with technical failure of MRE of the liver which necessitates the use of invasive liver biopsy as an alternative monitoring method for these patients. T2*-weighted magnetic resonance imaging (T2*) is a reliable modality to asses for hepatic as well as total body iron overload. Therefore, we aimed to determine a cutoff value on the T2* reading at which MRE would no longer provide accurate stiffness measurements in patients with iron overload.

Methods: Ninety-five patients with iron overload who underwent MRE at our institution, between 2010 and 2017 were reviewed retrospectively. We compared T2* values between patients with adequate elastography (N=63) versus those with non-diagnostic elastography (N=32). We additionally examined the ability of T2* to predict the likelihood of non-diagnostic elastography by estimating area under the ROC curve (AUC).

Results: T2* was significantly different between patients with and without an adequate elastography (P<0.0001) and predicted occurrence of non-diagnostic elastography with an AUC of 0.95. All patients with a non-diagnostic elastography had a T2* value below 20 milliseconds (ms), and correspondingly 55% of the patients with a T2* value below 20 ms had a non-diagnostic elastography. The subgroups of patients with a T2* value ≤10, ≤8, and ≤6 ms, had a higher likelihood of non-diagnostic elastography (87%, 92%, and 95%, respectively).

Conclusions: T2* can be used to accurately predict which patients are most likely to have a non-diagnostic elastography reading. T2* of 20 ms or lower reflects a higher likelihood of non-diagnostic elastography.

Keywords: Hemochromatosis; T2* cut-off value; magnetic resonance elastography (MRE).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
T2* values according to occurrence of non-diagnostic elastography. The sample median for each group is shown with a solid horizontal line.
Figure 2
Figure 2
ROC curve illustrating the ability of T2* to predict occurrence of non-diagnostic elastography. The area under the ROC curve (AUC) regarding the predictive ability of T2* was 0.95.

Similar articles

Cited by

References

    1. Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med 2012;366:348-59. 10.1056/NEJMra1004967 - DOI - PubMed
    1. Brissot P, Loreal O. Iron metabolism and related genetic diseases: A cleared land, keeping mysteries. J Hepatol 2016;64:505-15. 10.1016/j.jhep.2015.11.009 - DOI - PubMed
    1. Finch SC, Finch CA. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis. Medicine (Baltimore) 1955;34:381-430. 10.1097/00005792-195512000-00001 - DOI - PubMed
    1. Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004;127:S79-86. 10.1016/j.gastro.2004.09.019 - DOI - PubMed
    1. Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, Skipper LM, Jennings BA. Incidence of liver disease in people with HFE mutations. Gut 2000;46:401-4. 10.1136/gut.46.3.401 - DOI - PMC - PubMed